订阅小程序
旧版功能

Efficacy of Olaparib (O) Plus Abiraterone (A) Versus Placebo (P) Plus A in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (mcrpc) with Single Homologous Recombination Repair Gene Mutations (hrrm) in the PROpel Trial.

JOURNAL OF CLINICAL ONCOLOGY(2024)

引用 1|浏览6
关键词
Alpha Particle Therapy,Metastatic Prostate Cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要